Transplant-Free Survival Among Children With Hypoplastic Left Heart Syndrome Undergoing Hybrid Palliation
The first long-term evaluation of kids with hypoplastic left heart syndrome undergoing hybrid palliation procedures finds transplant-free survival similar to that of the standard treatment at age 15 years.
The complication that halted a clinical trial for tissue-engineered vascular grafts for children with congenital heart disease may reverse spontaneously without clinical complications.
The official billing code will enable growth of the subspecialty and is expected to result in improved patient care.
Data are still emerging, but COVID-19 – and the subsequent inflammatory syndrome sometimes seen in children – could have serious cardiac impacts.
Study Supports Expanded Use of Ventricular Assist Devices in Children With Complex Congenital Heart Disease
New multicenter study shows that the HeartMate3 ventricular assist device is associated with low morbidity and adverse events in pediatric patients with complex CHD.
Study suggests a low-risk subpopulation does not develop worsening heart conditions after initial test.
Heart problems have been reported in nearly all the neuromuscular disorders. They are particularly common and serious in Duchenne and Becker muscular dystrophies.
Faculty at Nationwide Children’s Hospital are focused on evaluating and customizing treatments for adults with congenital heart disease in order to improve clinical outcomes for these patients.
Investigators at Nationwide Children’s Hospital are focused on understanding the molecular pathways that regulate normal and abnormal heart development.
Faculty members at Nationwide Children’s Hospital are working to understand the genetic basis of congenital heart disease and are investigating how genetic and environmental factors play a role in the development of heart defects in children.
The Heart Center faculty members continue to investigate new surgical treatment options and ways to improve surgical outcomes.
Christopher Breuer, MD, discusses the research being done in the Center for Regenerative Medicine at Nationwide Children's Hospital. Dr. Breuer and his team are working on a tissue engineered heart valve and a tissue engineered vascular graft that grows with the patient.
You Might Also Be Interested In
Sign Up for PediatricsOnline
Subscribe to PediatricsOnline, a digital newsletter personalized for the pediatric provider to deliver up-to-date resources, research announcements and more.
The Heart Center
We offer cardiology services, cardiothoracic surgery, interventional cardiology (catheterization) and support for patients with all heart conditions from simple to complex. Pediatric and adult patients with congenital heart disease and acquired cardiomyopathy have access to world-class diagnostics, treatments and research.